{
  "zip": "92121",
  "sector": "Healthcare",
  "fullTimeEmployees": 4,
  "longBusinessSummary": "Emerald Bioscience, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of cannabinoid-based therapeutics for unmet medical needs worldwide. The company's lead product candidate is NB1111, which is in preclinical trials for the treatment of glaucoma. It is also developing NB2222, a product candidate in preclinical trials for use in the treatment of various eye diseases, including uveitis, dry eye syndrome, macular degeneration, and diabetic retinopathy; and NB3111, a cannabinoid cocktail in testing for use as an anti-infective agent against various strains of antibiotic resistant bacteria, including methicillin-resistant Staphylococcus aureus. The company was formerly known as Nemus Bioscience, Inc. and changed its name to Emerald Bioscience, Inc. in March 2019. Emerald Bioscience, Inc. was founded in 2012 and is based in San Diego, California.",
  "city": "San Diego",
  "phone": "949 480 9051",
  "state": "CA",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.emeraldbio.life",
  "maxAge": 1,
  "address1": "5910 Pacific Center Boulevard",
  "industry": "Biotechnology",
  "address2": "Suite 320",
  "previousClose": 0.1,
  "regularMarketOpen": 0.102,
  "twoHundredDayAverage": 0.05626619,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.1099,
  "navPrice": null,
  "averageDailyVolume10Day": 16535787,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.1,
  "fiftyDayAverage": 0.04218182,
  "trailingAnnualDividendRate": null,
  "open": 0.102,
  "averageVolume10days": 16535787,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.406512,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.0725,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 12606007,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 22131550,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 3799252,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.0725,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 12606007,
  "fiftyTwoWeekHigh": 0.2,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.025,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.1099,
  "exchange": "PNK",
  "shortName": "EMERALD BIOSCIENCE INC",
  "longName": "Emerald Bioscience Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "EMBI",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_266974060",
  "uuid": "5085cc83-86a5-38c7-bfef-efe244937ea5",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": -3.25,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 250074000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 0.007,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.18298,
  "netIncomeToCommon": -206540,
  "trailingEps": -0.042,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 12.642857,
  "heldPercentInsiders": 0.45651,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 117092343,
  "enterpriseValue": 22139234,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1414540800,
  "lastSplitFactor": "2:1",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.102,
  "logo_url": "https://logo.clearbit.com/emeraldbio.life"
}